Modulating gut microbiota as an anti-diabetic mechanism of berberine

Berberine, one of the main constituents of a Chinese traditional herb used to treat bacterial diarrhea, has an effect of lowering glucose, which has been recently confirmed by many studies. However, the mechanism of berberine's antidiabetic effect has not yet been well explained. Recent evidence suggests that the gut microbiota composition is associated with obesity and type 2 diabetes, which are closely associated with a low-grade inflammatory state. The protective effect against diabetes of gut microbiota modulation with probiotics or antibiotics has been confirmed in recent observations. Berberine has significant antimicrobial activity against several microbes through inhibiting the assembly function of FtsZ and halting the bacteria cell division. Because berberine acts topically in the gastrointestinal tract and it is poorly absorbed, berberine might modulate gut microbiota without systemic anti-infective activity. Our hypothesis is that gut microbiota modulation may be one mechanism of the antidiabetic effect of berberine. Our hypothesis may provide a novel explanation for berberine's therapeutic effect in patients with diabetes mellitus.

[1]  Shousi Lu,et al.  Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats. , 2008, Die Pharmazie.

[2]  E. Beachey,et al.  Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane , 1988, Antimicrobial Agents and Chemotherapy.

[3]  R. Berg,et al.  The indigenous gastrointestinal microflora. , 1996, Trends in microbiology.

[4]  Berberine monograph , 2002 .

[5]  Guangji Wang,et al.  Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. , 2008, The Journal of endocrinology.

[6]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Jianping Ye,et al.  Berberine improves glucose metabolism through induction of glycolysis. , 2008, American journal of physiology. Endocrinology and metabolism.

[8]  Jing-Gung Chung,et al.  Berberine Inhibits Arylamine N-Acetyltransferase Activity and Gene Expression in Salmonella Typhi , 2005, Current Microbiology.

[9]  R. Sack,et al.  Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins , 1982, Infection and immunity.

[10]  M. Membrez,et al.  Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice. , 2008, Nestle Nutrition workshop series. Paediatric programme.

[11]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  P. Kakkar,et al.  Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. , 2009, Journal of ethnopharmacology.

[13]  Anirban Bhunia,et al.  Berberine targets assembly of Escherichia coli cell division protein FtsZ. , 2008, Biochemistry.

[14]  Le Zhang,et al.  Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. , 2008, Biological & pharmaceutical bulletin.

[15]  Guangji Wang,et al.  Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. , 2010, Biochemical pharmacology.

[16]  G. Ning,et al.  Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.

[17]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[18]  T. Butler,et al.  Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. , 1987, The Journal of infectious diseases.

[19]  Jianping Ye,et al.  Efficacy of berberine in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[20]  Patrice D Cani,et al.  The role of the gut microbiota in energy metabolism and metabolic disease. , 2009, Current pharmaceutical design.

[21]  Xiao-dong Liu,et al.  Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[23]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[24]  I. Laher,et al.  Antioxidant therapy in human endocrine disorders. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[25]  Y. Ni.  [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research]. , 1988, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine.

[26]  M. Marinaro,et al.  Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse , 2005, Diabetologia.

[27]  H. Yadav,et al.  Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. , 2007, Nutrition.

[28]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[29]  D. James,et al.  Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.